Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Scientia Pharmaceutica
ISSN 0036-8709 · eISSN 2218-0532 · Multidisciplinary Digital Publishing Institute (MDPI) · Austria
Scientia Pharmaceutica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); JCR Q2 (journal website); fully open access; APC charged, amount not published; review about 10 weeks (community reports); 63 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Scientia Pharmaceutica is published by Multidisciplinary Digital Publishing Institute (MDPI) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Analytical Chemistry and Chromatography and Drug Solubulity and Delivery Systems, together about 30.6% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
AimsScientia Pharmaceutica (ISSN 2218-0532)– Official Organ of the Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG) – publishes original research papers, short communications and a limited number of reviews from all fields of pharmaceutical sciences and related disciplines, as well as from pharmaceutical practice.ScopeIn particular the following areas are covered: Medicinal and Pharmaceutical Chemistry: Synthesis, analysis and modelling of biologically active substances and pharmaceuticals Pharmacognosy and Pharmaceutical Biology: Isolation and structure elucidation of natural substances; morphology, systematics, taxonomy of medicinal and poisonous plants; quality of medicines of biological origin Pharmacology: pharmacological testing of synthetic and natural products; clinical pharmacy; mechanisms of drug (inter-)actions Pharmaceutical Technology: Strategies of drug development; controlled drug release; drug targeting Contributions on pharmacy-didactics, pharmaeconomy, nutritional sciences, book reviews, and proposals for pharmacopoeia-monograph MDPI Publication Ethics Statement MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.Book ReviewsAuthors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section. MDPI Grosspeteranlage 5 CH-4052 Basel Switzerland Copyright / Open AccessArticles published in Sci. Pharm. will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Published by MDPI on behalf of the Österreichische Pharmazeutische Gesellschaft. Licensee MDPI, Basel, Switzerland. Thi
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry11.9%
- Analytical Chemistry and ChromatographyChemistry10%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.7%
- Synthesis and biological activityChemistry6.7%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.6%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.9%
- Computational Drug Discovery MethodsComputer Science4.4%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · Pharmacology and Pharmacy
- CiteScore Q2 · Pharmaceutical Science
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher)
- 5.3Publisher website ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.95LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 625OpenAlex ·
- 2-year mean citedness
- 3.23OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 99.47%LetPub ·
Volume
- Articles per year
- 64LetPub ·
Articles by year OpenAlex count · 1,681 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 79 | 37 |
| 2025 | 63 | 63 | 227 |
| 2024 | 64 | 64 | 402 |
| 2023 | 56 | 56 | 616 |
| 2022 | 73 | 73 | 831 |
| 2021 | 52 | 52 | 933 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 24.8 daysPublisher website ·
- Acceptance to publication
- 4.5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,000 | Yes | CC BY | |
| OpenAlex | CHF 1,000 | — | — | |
| LetPub | CHF 1,000 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 200 words
- Reference style
- Author–date
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted19
- articleArticle: These are original research manuscripts. The work should report scientifically sound experiments and provide a substantial amount of new information.Length not stated
- book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …
Source ↗Publisher website ·- Publication ethics Publication Ethics Statement
Sci. Pharm. is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsifi…
Source ↗Publisher website ·- License & copyright Copyright / Open Access
Articles published in Sci. Pharm. will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Published by MDPI on behalf of the Österreichische Pharmazeutische Gesellschaft. Licensee MDPI, Basel, S…
Source ↗Publisher website ·- Open access Open access publication fees
Free format submission accepted Model summary
If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.
Source ↗Publisher website ·- Peer review Editorial Process and Peer Review
All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …
Source ↗Publisher website ·- Preprints Preprints and Conference Papers
Sci. Pharm. accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates independ…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Country or region
- Austria
- Language
- English
- ISSN
- 0036-8709
- Electronic ISSN
- 2218-0532
- Society / sponsor
- Austrian Pharmaceutical Society
- Latest issue on the website
- Volume 94 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Scientia Pharmaceutica
What CAS zone is Scientia Pharmaceutica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Scientia Pharmaceutica is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Scientia Pharmaceutica?
The journal's website gives an impact factor of 3.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.3, h-index 67.
How long does peer review take at Scientia Pharmaceutica?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Scientia Pharmaceutica in?
The journal's website gives JCR Q2; by category, Pharmacology and Pharmacy Q2. JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
What are the manuscript requirements of Scientia Pharmaceutica?
According to the journal's author guidelines: Abstract: ≤ 200 words; Reference style: Author–date; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Scientia Pharmaceutica?
According to LetPub and DOAJ records, Scientia Pharmaceutica is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, Embase and CAS; that list has not been checked against each database.
Is Scientia Pharmaceutica open access, and what is the APC?
Scientia Pharmaceutica is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .